Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

533.55 15.09 −2.75%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

Chemed Corporation (CHE) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Chemed Corporation (CHE) trades at a P/S ratio of 2.6×. Over the past ten years it has ranged from 1.2× (January 2015) to 4.3× (March 2024); the current reading is higher than 36% of that period. That is above the Medical Care Facilities industry median of 1.0× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 2.4× (25.63%)
FY2024 3.3× (15.73%)
FY2023 3.9× 9.61%
FY2022 3.5× (8.54%)
FY2021 3.9× (5.16%)
FY2020 4.1× 12.93%
FY2019 3.6× 41.79%
FY2018 2.6× 7.25%
FY2017 2.4× 41.28%
FY2016 1.7× 2.86%

Quarterly newest first

Period P/S ratio Change
Sep 2026 2.5× 4.82%
Jun 2026 2.4× 16.28%
Mar 2026 2.0× (16.49%)
Dec 2025 2.4× (4.39%)
43 more quarters

Against its own ten years

Low 1.2× High 4.3×
Ten-year median 3.1×
Current reading's percentile 30

P/S ratio against peers

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on CHE